Filing Flows › Indivior Pharmaceuticals (INDV) › How it makes money
How Indivior Pharmaceuticals (INDV) makes money
Indivior Pharmaceuticals (INDV) made $356M of revenue in the third quarter 2026 (Q3 2026), +13% from a year earlier. Of every dollar of revenue, 86¢ was left as gross profit, 51¢ was left as operating profit, 38¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $356M | 100.0% |
| Cost of revenue | $51.0M | 14.3% |
| Gross profit | $305M | 85.7% |
| Operating expenses | $125M | 35.1% |
| Operating profit | $180M | 50.6% |
| Income tax | $45.0M | 12.6% |
| Net earnings | $137M | 38.5% |
| Operating cash flow | $97.0M | 27.2% |
| Free cash flow | $83.0M | 23.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $356M | +13% |
| Q2 2026 | $343M | +14% |
| Q1 2026 | $317M | +19% |
| Q4 2025 | $358M | +20% |
| Q3 2025 | $314M | +2% |
| Q2 2025 | $302M | +1% |
| Q1 2025 | $266M | -6% |
From Indivior Pharmaceuticals' 10-Q filed Oct 29, 2026 (on EDGAR).
Questions
How does Indivior Pharmaceuticals make money?
Indivior Pharmaceuticals (INDV) made $356M of revenue in the third quarter 2026 (Q3 2026), +13% from a year earlier. Of every dollar of revenue, 86¢ was left as gross profit, 51¢ was left as operating profit, 38¢ was left as net earnings.
What is Indivior Pharmaceuticals' profit margin?
Net earnings were $137M, 38.5% of revenue, in the third quarter 2026; the operating margin was 50.6%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.